Literature DB >> 25620873

Noninvasive evaluation of left ventricular force-frequency relationships by measuring carotid arterial wave intensity during exercise stress.

Midori Tanaka1, Motoaki Sugawara1, Yasuo Ogasawara2, Isao Suminoe3, Tadafumi Izumi4, Kiyomi Niki5, Fumihiko Kajiya2.   

Abstract

BACKGROUND AND
PURPOSE: Estimation of the contractility of the left ventricle during exercise is important in drawing up a protocol of cardiac rehabilitation. It has been demonstrated that color Doppler- and echo tracking-derived carotid arterial wave intensity is a sensitive index of global left ventricular (LV) contractility. We assessed the feasibility of measuring carotid arterial wave intensity and determining force-frequency (contractility-heart rate) relations (FFRs) during exercise totally noninvasively.
METHODS: We measured carotid arterial wave intensity with a combined color Doppler and echo tracking system in 25 healthy young male volunteers (age 20.8 ± 1.2 years) at rest and during exercise. FFRs were constructed by plotting the maximum value of wave intensity (WD1) against heart rate (HR).
RESULTS: We first confirmed that HR increased linearly with an increase in work load in each subject (r (2) = 0.95 ± 0.04). WD1 increased linearly with an increase in HR. The goodness-of-fit of the regression line of WD1 on HR in each subject was very high (r (2) = 0.48-0.94, p < 0.0001, respectively). The slope of the WD1-HR relation ranged 0.30-2.20 [m/s(3) (beat/min)].
CONCLUSIONS: Global LV FFRs can be generated in healthy young volunteers with an entirely noninvasive combination of exercise and wave intensity. These data should show the potential usefulness of the FFR in the context of cardiac rehabilitation.

Entities:  

Keywords:  Echocardiography; Exercise; Force−frequency relation; Wave intensity

Mesh:

Year:  2014        PMID: 25620873      PMCID: PMC4300423          DOI: 10.1007/s10396-014-0554-8

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


Introduction

Evaluation of the changes in the contractile state of the left ventricle during exercise is an important, and as yet not easy, goal in the procedure for cardiac rehabilitation. The positive inotropic effect of increasing the frequency of contraction in isolated cardiac muscles has been known as the Bowditch effect or the staircase phenomenon. The positive inotropic effect of increased heart rate (HR) produced by pacing also has been demonstrated in healthy human subjects, which has been called the force−frequency relation (FFR) [1, 2]. In conventional methods of obtaining FFRs, the maximum rate of left ventricular (LV) pressure rise (peak dP/dt) measured with a catheter-tipped micromanometer was used as an index of cardiac contractility, and atrial pacing was used to change HR (peak dP/dt−HR relation). It has also been reported that the FFR is significantly affected in hearts with a variety of diseases [3-7]. During exercise, HR increases with an increase in workload; therefore, atrial pacing is not needed for changing HR. It has also been demonstrated that the peak dP/dt−HR relation is markedly enhanced (the slope is increased) during exercise compared with during pacing in normal hearts, but the enhancement is limited in diseased hearts [8]. The FFR obtained by exercise may have higher power to discriminate cardiac contractile states than that obtained by pacing. In spite of its potential for evaluating cardiac function during exercise, peak dP/dt−HR relation has not been widely used because of its invasive nature. We have reported that carotid arterial wave intensity (WI) noninvasively measured with a combined system of color Doppler and echo tracking is a sensitive index of global LV contractile function (Fig. 1) [9, 10].
Fig. 1

Relation between W1 obtained by carotid arterial echography and max dP/dt obtained with a catheter-tipped micromanometer (From Ohte N et al. [9])

Relation between W1 obtained by carotid arterial echography and max dP/dt obtained with a catheter-tipped micromanometer (From Ohte N et al. [9]) In this study, we assessed the usefulness of WI to measure LV contractility and FFRs during exercise in healthy subjects, and evaluated the feasibility of an entirely noninvasive method for demonstration of the global LV FFR.

Materials and methods

Definition of wave intensity in terms of diameter-change

Wave intensity (WI) is a hemodynamic index, which is defined aswhere dP/dt and dU/dt are the derivatives of blood pressure (P) and velocity (U) with respect to time, respectively. The maximum value of WI during a cardiac cycle (W1) significantly correlates with peak dP/dt (or max dP/dt) (Fig. 1) [9]. In our method of obtaining carotid arterial WI, the carotid diameter-change waveform was used as a surrogate for carotid pressure waveform. Using the diameter-change waveform directly, we can also define another wave intensity (WD) aswhere D is the diameter. We can obtain the relation of WD to WI as follows: The definition of the stiffness parameter, β, is written aswhere D is the diameter at pressure P, and Dd is the diameter at the end-diastolic pressure Pd. The above equation gives: The differentials of both sides of the above equation give Since the difference between D and Dd is small (Fig. 2), Dd can be replaced by D. Then, we obtain which giveswhere dD/dt and dP/dt are the time derivatives of D and P, respectively. Substituting Eq. 3 into Eq. 2 and using Eq. 1, we obtain
Fig. 2

Representative recordings of carotid arterial diameter (D) and blood flow velocity (U), and calculated wave intensity (WD) in a healthy human. WD is the wave intensity defined by using D as WD = (1/D) (dD/dt) (dU/dt)

Figure 2 shows the WD waveform calculated from the diameter-change waveform and the velocity waveform. According to Eq. 4, the maximum value of carotid arterial WD during a cardiac cycle (WD1) correlates with the maximum value of WI (W1). Therefore, WD1 correlates with peak dP/dt as W1 does (Fig. 1). WD is obtained by measuring U and D without measuring upper arm pressure (Fig. 3), which is easier to perform during exercise. The details of the method of measurements were described elsewhere [11].
Fig. 3

Measurements of diameter-change waveform and blood velocity. Left Long axis view of the common carotid artery and ultrasound beams. By setting the tracking positions displayed as small pink bars on the echo tracking beam (line A) to arterial walls, echo tracking automatically starts. The blood flow velocity averaged along the Doppler beam (line B) crossing the artery was measured using range-gated color Doppler signals. Right The diameter-change waveform, which is calculated by subtracting the distance to the near wall from that to the far wall, is displayed on the M-mode view. The blood flow velocity waveform is also displayed on the M-mode view

Representative recordings of carotid arterial diameter (D) and blood flow velocity (U), and calculated wave intensity (WD) in a healthy human. WD is the wave intensity defined by using D as WD = (1/D) (dD/dt) (dU/dt) Measurements of diameter-change waveform and blood velocity. Left Long axis view of the common carotid artery and ultrasound beams. By setting the tracking positions displayed as small pink bars on the echo tracking beam (line A) to arterial walls, echo tracking automatically starts. The blood flow velocity averaged along the Doppler beam (line B) crossing the artery was measured using range-gated color Doppler signals. Right The diameter-change waveform, which is calculated by subtracting the distance to the near wall from that to the far wall, is displayed on the M-mode view. The blood flow velocity waveform is also displayed on the M-mode view Thus, we can regard the WD1-HR relation as the FFR.

Subjects

We studied 25 healthy male volunteers (mean age 20.8 ± 1.2 years, age range 19−23 years) (Table 1). We obtained informed consent from all the subjects. Approval from the Ethics Committee of Himeji Dokkyo University was obtained before study initiation.
Table 1

Baseline data of all the subjects

SubjectAge (years)Height (cm)Weight (kg)BMI (kg/m2)HR at rest (bpm)WD1 at rest (m/s3)
a231716421.96527.77
b231716421.97432.19
c211756220.26110.17
d211635520.78422.94
e211706020.87419.00
f201726522.06520.71
g211735418.0828.95
h191756320.67818.00
i211718729.87322.40
j221726622.37423.00
k191777122.7619.10
l191605621.98850.00
m191806921.36219.00
n211737023.46222.40
o221706020.87917.40
p211686322.37617.10
q211595521.810423.60
r221688530.17425.50
s211735317.77436.50
t191605220.36633.74
u221769029.18413.66
v221747825.87134.98
w191776019.27144.51
x211655018.47342.02
y211725418.38627.29
Mean20.8170.664.222.074.324.9
SD1.25.410.83.39.910.6
Baseline data of all the subjects

Protocol

Subjects were asked to refrain from caffeine, alcohol, and exercise during the 24-h period before the test. Before the measurements of WD1 and HR, the subjects were laid down the supine position for 10 min. The location to be measured was the right common carotid artery at about 2 cm proximal to the carotid bulb. We used scanning in the long axis view, and obtained a B-mode image of a longitudinal section of the artery (Fig. 3, left). With the B- and M-mode scans displayed simultaneously on a split screen, the echo tracking system tracked the vessel wall movements to produce displacement waveforms of the anterior and posterior artery walls (Fig. 3, right). This gave the diameter-change waveforms. After the measurements of WD1 and HR at rest, gradual bicycle exercise was performed starting at an initial workload of 20 W and lasting for 2 min; thereafter, the workload was increased stepwise by 20 W at 1 min intervals. Electrocardiogram was continuously monitored. The criteria for the endpoint included increase of heart rate to [(220-age) × 0.8 (bpm)], and achievement of maximum fatigue or the impossibility of continuing exercise. We measured WD1 and HR during the exercise.

Statistical analysis

The obtained data are expressed as mean ± standard deviation. The scatter diagram of the points (WD1, HR) for the data during exercise from each subject was analyzed by the linear regression method, and the regression line was regarded as the FFR. A value of p < 0.05 was considered statistically significant.

Results

The baseline data from the subjects are shown in Table 1. We first confirmed that HR increased linearly with an increase in work load in all the subjects (r2 = 0.95 ± 0.04) (Fig. 4). WD1 increased linearly with an increase in HR (Fig. 5). The goodness-of-fit of the regression line of WD1 on HR in each subject was very high (r2 = 0.8 ± 0.1, p < 0.0001, respectively). The slope of the WD1-HR relation ranged from 0.30 to 2.20 [m/s3 (beat/min)] (mean ± SD: 1.0 ± 0.4 [m/s3 (beat/min)]). Figure 5 contains the WD1-HR relation with the greatest slope, that with the smallest slope, and those with moderate slopes.
Fig. 4

A representative relation between heart rate (HR) (bpm) and work load (W) in healthy male subjects. The solid line indicates the linear regression line, and the dotted curves show the 95 % confidence band of the regression line

Fig. 5

Relations between the maximum values of WD (WD1) and heart rate (HR) (bpm). As representative data, WD1-HR relation with the greatest slope, that with the smallest slope, and those with moderate slopes are shown. The solid lines indicate the regression lines. The dotted curves show the 95 % confidence bands of the regression lines

A representative relation between heart rate (HR) (bpm) and work load (W) in healthy male subjects. The solid line indicates the linear regression line, and the dotted curves show the 95 % confidence band of the regression line Relations between the maximum values of WD (WD1) and heart rate (HR) (bpm). As representative data, WD1-HR relation with the greatest slope, that with the smallest slope, and those with moderate slopes are shown. The solid lines indicate the regression lines. The dotted curves show the 95 % confidence bands of the regression lines

Discussion

It has been reported that the basic property of the force−frequency effect to progressively enhance myocardial contractility as the heart rate increases is markedly augmented due to β-adrenergic stimulations induced by exercise in normal hearts [12, 13]. This possibility was examined in conscious dogs through the study of force−frequency effects during graded infusions of the β-adrenergic receptor agonist dobutamine under resting conditions. During infusions of low, medium, and high doses of dobutamine, the heart rate varied from 100 to 210 bpm by atrial pacing. During the dobutamine infusions, LV peak dP/dt progressively increased as the heart rate was augmented; the increase was greater at high doses than at low doses of dobutamine [14]. Thus, the regulatory effect of enhanced β-adrenergic stimulation on the FFR is as important as the basal FFR during exercise [15]. Significant impairment of β-adrenergic amplification of the FFR has been observed in heart failure, which could contribute to impaired cardiac contractility during exercise [16, 17]. Accordingly, one would expect that the diversity of responses of the FFR to β-adrenergic stimulations induced by exercise affords increased sensitivity for detection of contractile impairment. One group has used exercise echocardiography to demonstrate FFRs noninvasively [18]. However, in contrast to the present study, their index (systolic blood pressure/end-systolic volume) was a rarely used and unvalidated index of contractility. Several other groups have used tissue Doppler-derived isovolumic acceleration (IVA) during exercise, and presented FFR curves [19-21]. However, IVA is a parameter of regional myocardial contractility of the LV wall, and does not necessarily represent the global contractile state of the left ventricle. Indeed, IVA values vary considerably according to the region of interest of the LV wall. In some cases, IVA obtained from the mid lateral wall is more than 50 % greater than that obtained from the basal anterior wall [22]. In addition, the IVA-HR relation during exercise is not linear [21], in contrast to the linear WD1-HR relation. It is always easier to characterize a linear relation than to characterize a nonlinear relation. Equation 4 shows that WD contains β. It is widely known that β increases with age. However, our study subjects only ranged from 19 to 23 years old. Therefore, β was considered to vary only slightly with the individual. In spite of this, the slope of the FFR varied relatively widely. This is considered to show that the FFR during exercise is determined mainly by the cardiac contractile state rather than arterial conditions.

Limitations

Although the WD1-HR relation depends on age, our study subjects only ranged from 19 to 23 years old. We should enroll a greater number of subjects to be divided into age groups in a future study. The final goal of our study is to apply the force−frequency relation to cardiac rehabilitation. However, we did not enroll patients with heart diseases in the present feasibility study.

Conclusions

Measurements of carotid arterial wave intensity by echocardiography during exercise give the FFR noninvasively. This will be useful for evaluation of the contractile state of the left ventricle during exercise for cardiac rehabilitation.
  22 in total

1.  Clinical usefulness of carotid arterial wave intensity in assessing left ventricular systolic and early diastolic performance.

Authors:  Nobuyuki Ohte; Hitomi Narita; Motoaki Sugawara; Kiyomi Niki; Takashi Okada; Akimitsu Harada; Junichiro Hayano; Genjiro Kimura
Journal:  Heart Vessels       Date:  2003-07       Impact factor: 2.037

2.  Influence of ouabain on the force-frequency relationship in cardiac muscle.

Authors:  P K Singal; K Prasad
Journal:  Jpn Heart J       Date:  1979-05

3.  Force-frequency relationship. A basis for a new index of cardiac contractility?

Authors:  P A Anderson; A Manring; E A Johnson
Journal:  Circ Res       Date:  1973-12       Impact factor: 17.367

4.  A new noninvasive measurement system for wave intensity: evaluation of carotid arterial wave intensity and reproducibility.

Authors:  Kiyomi Niki; Motoaki Sugawara; Dehua Chang; Akimitsu Harada; Takashi Okada; Ryoichi Sakai; Keisuke Uchida; Rie Tanaka; Catherine E Mumford
Journal:  Heart Vessels       Date:  2002-11       Impact factor: 2.037

5.  Influence of the force-frequency relation on left ventricular function during exercise in conscious dogs.

Authors:  T Miura; S Miyazaki; B D Guth; M Kambayashi; J Ross
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

6.  Evaluation of the force-frequency relationship as a descriptor of the inotropic state of canine left ventricular myocardium.

Authors:  P A Anderson; J S Rankin; C E Arentzen; R W Anderson; E A Johnson
Journal:  Circ Res       Date:  1976-12       Impact factor: 17.367

7.  Noninvasive assessment of left ventricular force-frequency relationships using tissue Doppler-derived isovolumic acceleration: validation in an animal model.

Authors:  Michael Vogel; Michael M H Cheung; Jia Li; Steen B Kristiansen; Michael R Schmidt; Paul A White; Keld Sorensen; Andrew N Redington
Journal:  Circulation       Date:  2003-03-17       Impact factor: 29.690

8.  Enhancement of the force-frequency effect on myocardial contractility by adrenergic stimulation in conscious dogs.

Authors:  M Kambayashi; T Miura; B H Oh; H A Rockman; K Murata; J Ross
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

9.  Effects of beta-blockade on regional myocardial flow and function during exercise.

Authors:  M Matsuzaki; J Patritti; T Tajimi; M Miller; W S Kemper; J Ross
Journal:  Am J Physiol       Date:  1984-07

10.  Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy.

Authors:  G Hasenfuss; C Holubarsch; H P Hermann; K Astheimer; B Pieske; H Just
Journal:  Eur Heart J       Date:  1994-02       Impact factor: 29.983

View more
  1 in total

1.  Noninvasive assessment of exercise tolerance using mitral annular velocities.

Authors:  Yasuyuki Hadano; Masunori Matsuzaki
Journal:  J Med Ultrason (2001)       Date:  2015-09-16       Impact factor: 1.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.